The Medical Coatings Market is projected to reach $3.32 billion by 2030, at a CAGR of 11.20% from 2024 to 2030. Medical devices, implants, and equipment are highly specialized and require a coating of specific materials. The surface coating of medical devices improves performance and, most importantly, the safety of the devices. The medical implants placed inside the body must be compatible with the human tissue. Medical coatings are required to ensure that the device that comes in contact with human tissues is biocompatible.
The growth of this market is driven by factors such as the rising incidence of healthcare-associated infections (HAIs), growing adoption of minimally invasive surgical procedures, and high demand from the medical devices industry. Furthermore, the growing demand for customized and multifunctional coatings and potential in emerging economies are expected to provide significant growth opportunities for this market.
However, the rising raw material prices and high costs & miniaturization of medical devices are the factors that are expected to hinder the growth of this market. Additionally, factors such as the limitations of certain types of coatings with regards to biocompatibility, lack of standardization, and durability, among others and the risk of coating failure associated with the use of hydrophilic and/or hydrophobic coated medical devices are some of the major challenges for the growth of this market.
High Incidence of Healthcare-associated Infections (HAIs)
Hospital-acquired infections (HAIs), also known as nosocomial infections, are diseases acquired in hospitals or healthcare facilities that manifest 48 hours or more after admission or within 30 days of discharge. According to the WHO, out of every 100 hospitalized patients, seven in developed and ten in developing countries acquire at least one healthcare-associated infection. Also, the prevalence of device-associated infections in developing countries is up to 13 times higher than in developed countries.
It is reported that each year around 313 million surgeries are performed globally. According to the WHO, surgical site HAIs are observed frequently, with an incidence rate of 0.5% to 15% out of total surgeries. It has been reported by the Centers for Disease Control and Prevention (CDC) that approximately 27 million surgical procedures are performed in the U.S. each year, with up to 5% of patients acquiring surgical site infections.
Some medical coatings contain antimicrobial agents that prevent the growth of bacteria and other harmful pathogens. They can also be a barrier between the medical device and the patient's body, preventing contamination. Cleaning and disinfecting medical devices are made easier with medical coatings that have smooth and non-porous surfaces. Additionally, biocompatible and non-toxic coatings can reduce adverse reactions in patients, including infections. Lastly, medical coatings that reduce friction can lower the risk of device-related injuries, increasing the risk of infection. By reducing the risk of HAIs, medical coatings can improve patient outcomes and decrease the healthcare costs associated with treating infections.
Click here to: Get a Free Sample Copy of this report
Key Findings of the Medical Coatings Market Study:
In 2024, the Hydrophilic Coatings Segment is Expected to Dominate the Medical Coatings Market
Based on type, the hydrophilic coatings market is segmented into hydrophilic coatings, antimicrobial coatings, drug-eluting coatings, anti-thrombogenic coatings and other types. In 2024, the hydrophilic coatings segment is expected to account for the largest share of the medical coatings market. The large market share of this segment is attributed to the high demand for hydrophilic-coated medical devices due to its advantages such as reduced friction, increased lubrication, and high compatibility with blood & other body fluids.
In 2024, the Polymers Segment is Expected to Account for the Largest Share of the Medical Coatings Market
Based on material type, the medical coatings market is segmented into polymers, metals, and other material types. In 2024, the polymers segment is expected to account for the largest share of the medical coatings market. The large market share of this segment can be attributed to the ability of polymers to effectively improve durability and provide corrosion resistance and better biocompatibility. Further, a variety of types of polymers are available for different types of applications, such as fluoropolymer coatings, which have the property to provide dry lubrication, insulation, and non-stick properties.
In 2024, the Medical Devices Segment is Expected to Account for the Largest Share of the Medical Coatings Market
Based on application, the medical coatings market is segmented into medical devices, medical implants, medical equipment & surgical tools, and other applications. In 2024, the medical devices segment is expected to account for the largest share of the medical coatings market. The large market share of this segment is attributed to the increased demand for medical devices such as guidewires, endotracheal tubes, catheters, etc., and the ability of medical coatings to improve patient safety and reduce infections.
Asia-Pacific: The Fastest-growing Market
Asia-Pacific is slated to register the fastest growth rate in the medical coatings market during the forecast period. The high market growth in Asia-Pacific is attributed to the growing medical devices market in the region, increasing number of surgeries, growing hospitalization rates, and rising healthcare expenditure.
Key Players
The report includes a competitive landscape based on an extensive assessment of mode of use, type, application, end user, geographic presence, and the key growth strategies adopted by leading market players in the industry over the past years 2020–2022. The key players profiled in the medical coatings market are Hydromer Inc. (U.S.), Harland Medical Systems, Inc. (U.S.), SurModics, Inc. (U.S.), Koninklijke DSM N.V. (Netherlands), AST Products, Inc. (U.S.), Biocoat Incorporated (U.S.), Precision Coating Company, Inc (U.S.), Medicoat AG (Switzerland), Merit Medical Systems, Inc. (U.S.), and Specialty Coating Systems, Inc. (U.S.).
Scope of the Report:
Medical Coatings Market, by Type
- Hydrophilic Coatings
- Antimicrobial Coatings
- Drug-eluting Coatings
- Anti-thrombogenic Coatings
- Other Types
(Other types include antiviral coatings, hydrophobic coatings, and corrosion-resistant coatings, among others)
Medical Coatings Market, by Material Type
- Polymers
- Fluoropolymers
- Polytetrafluoroethylene (PTFE)
- Polyvinylidene fluoride (PVDF)
- Other Fluoropolymers
- Parylene
- Silicones
- Other Polymers
- Metals
- Silver
- Titanium
- Other Metals
- Other Material Types
(Other polymers include nylon/polyamide, PEBAX, polyurethane, chloroprene, tecothane, tecoflex, and rubber (Including ethylene propylene diene monomer (EPDM), fluoroelastic, and natural rubber), among others)
(Other fluoropolymers include Xylan, Polyphenylene Sulfide (PPS), Fluorinated Ethylene Propylene (FEP), and Perfluoroalkoxy (PFA), among others)
(Other metals include stainless steel, nitinol, platinum, gold, nickel, and titanium, among others)
(Other material types include acrylic and ceramic, among others)
Medical Coatings Market, by Application
- Medical Devices
- Neurological Devices
- Cardiovascular Devices
- Ophthalmology Devices
- Orthopedics Devices
- Dental Devices
- Gynecology Devices
- Other Devices
- Medical Implants
- Orthopedic Implants
- Dental Implants
- Cardiovascular Implants
- Other Implants
- Medical Equipment & Surgical Tools
- Other Applications
(Other applications include coating for protective clothing, hospital furniture, and treatment seating, among others)
Medical Coatings Market, by Geography
- North America
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe (RoE)
- Asia-Pacific
- China
- Japan
- India
- Rest of APAC (RoAPAC)
- Latin America
- Brazil
- Mexico
- Rest of Latin America (RoLATAM)
- Middle East & Africa
Key questions answered in the report:
